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aused by birth trauma, malformation, stroke,
brain tumor or head injury and affecting as
much as 1 percent of the population, epilepsy is
one of the least understood human disorders in the
most complicated of organs – the brain.
Groundbreaking work to unlock the disease’s
cure is in motion in the lab of Jeffrey Loeb, M.D.,
Ph.D., associate professor of neurology, member of
the WSU/DMC Comprehensive Epilepsy Program
and associate director of the Center for Molecular
Medicine and Genetics in the School of Medicine.
By applying a systems biology approach to the
study of human epileptic brain tissue, Loeb and
his team are working to identify a “final common
pathway” of genes consistently induced at human
epileptic foci. Using this pathway as a drug target,
Loeb and his team will work to develop drugs that
successfully prevent epilepsy, first in rats, then
in humans.
This work is being performed with the Systems
Biology of Epilepsy Project (SBEP), a multidisciplinary collaboration between Wayne State
experts in areas ranging from neurosurgery to
information technology. The project catalogs
donated human epileptic brain tissues into an
integrative, one-of-a-kind database, using the
power of systems and computational biology
to understand the disease through its electrical,
anatomical and molecular features. Funded by
WSU’s President’s Research Enhancement Program
and the National Institutes of Health (NIH),
the goals of the SBEP are to find biomarkers –
substances or other characteristics that can be
used for diagnosis – and drug targets for
epilepsy therapeutics.
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the most important to the diagnosis and treatment
of epilepsy,” Loeb said. “I am not aware of any
other programs with a database that catalogs
epileptic tissue so comprehensively.”

From animal model to
human medicine
Loeb recently received NIH funding for a drug
development facility and is partnering with drug
companies to develop human drugs from his animal
model. If successful, the human version of the drug
will prevent human epilepsy in its early stages,
before seizures ever occur. “I call it the epilepsy
morning after pill,” Loeb said. “If you’re out riding
a bike without a helmet and you fall and hit your
head, taking this drug after the accident could
prevent you from developing epilepsy.”
Loeb will also investigate if the same drug can be
used to cure epilepsy in patients months or years
after a brain injury, when seizures begin.
Another major goal of the SBEP is improving
diagnosis. Current noninvasive EEG techniques
can only detect very large interictal spikes, with
the more subtle electric activity requiring surgery
in which the scalp is removed and electrodes are
placed directly on the brain. Loeb is working
to develop more powerful noninvasive
screening methods.
“By developing a method that gives us a higher
resolution, we would dramatically improve our
ability to treat epilepsy patients on a number of
levels, from greater success in early diagnosis, to
finding more biomarkers and developing better
therapeutics,” Loeb said.
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About Dr. Jeffrey Loeb
Dr. Loeb received his M.D. and Ph.D. in biochemistry
and molecular biology, his S.M. in biochemistry and
his A.B. in chemistry from the University of Chicago.
Following a neurology residency at Massachusetts
General Hospital and postdoctoral work in the
Department of Neurobiology at Harvard Medical
School, he joined Wayne State University in 1998.
Loeb will continue to build and maintain the
database of epileptic tissue with the ultimate
goals of developing diagnosis and disease-curing
treatment for epilepsy at every stage by building
and maintaining the project’s growing database of
epileptic tissue. “We’re hoping to be successful on
all fronts of disease diagnosis and prevention,” Loeb
said. “This work would not be possible without the
strong Wayne State expertise and the patients who
allow us to study their brain tissue in hopes to put
an end to this life-altering disease.”
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The project has several distinct advantages over
other epilepsy research, one being the ability to
study the disease in human brain tissue. “With
many diseases, particularly those of the brain,
researchers treat animals and then try to bring
the treatment to patients, and that doesn’t always
work,” Loeb said. “That’s why donated brain tissue
is such an invaluable gift; it gives us the unique
opportunity to start with the human disease and
understand it at a level that we never could before.”
Another unique aspect of the project is its
use of systems biology – the ability to obtain,
integrate and analyze complex data from multiple
experimental sources using interdisciplinary tools.
“From the neurosurgeons performing brain-removal
surgery to the IT experts that maintain our database,
it’s the collaboration of first-rate researchers that
makes this project work,” Loeb said.
Donated from epilepsy patients who underwent
brain surgery at Harper University Hospital and
Children’s Hospital of Michigan, each epileptic
tissue sample has a profile in the database that
includes the patient’s clinical information, genes
and proteins expressed and a 3-dimensional
computer rendering of the tissue with a heat map
of hot spots of electrical activity. The map identifies
the location of seizures as well as interictal spikes
– the minor, more frequent electrical discharges in
the brain that occur between seizures.
The database can then process common
characteristics and other relational information
about the tissues. “We don’t look at one particular
gene, pathway or protein, but at everything
simultaneously and determine which variables are
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To learn more, visit: http://www.sbep.wayne.edu/
joomla/index.php?option=com_frontpage&Itemid=1
and http://www.genetics.wayne.edu/jloeb
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